Losartan/hydrochlorothiazide
Combination of | |
---|---|
Thiazide diuretic | |
Clinical data | |
Trade names | Hyzaar, Cozaar comp, others |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
KEGG | |
CompTox Dashboard (EPA) |
Losartan/hydrochlorothiazide, sold under the brand name Hyzaar among others, is a
Common side effects include dizziness, back pain, and upper respiratory tract infections.
The combination was approved for medical use in the United States in 1995.
Medical uses
The combination is
Side Effects
Common side effects include dizziness, headache, back pain, rash, fever, diarrhea, cough, and upper respiratory tract infections.
Drug interactions
Drug interactions include lithium, agents increasing serum levels of potassium, nonsteroidal anti-inflammatory drugs (NSAIDs), antidiabetic drugs, cholestyramine, and colestipol.[1]
Mechanisms
Losartan works by blocking the effects of
Society and culture
Brand names
The losartan/hydrochlorothiazide combination preparation is marketed by Merck under the brand name Hyzaar and by Xeno Pharmaceuticals under the name Anzaplus.[6] Merck, Sharp & Dohme market it as Ocsaar Plus in Israel. It is marketed as Cozaar comp in Sweden and South Africa.
References
- ^ a b c d e f g h i j k l m n "Hyzaar- losartan potassium and hydrochlorothiazide tablet, film coated". DailyMed. Retrieved 31 March 2021.
- ^ ISBN 9780857113382.
- ^ "Hydrochlorothiazide / losartan Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Hydrochlorothiazide; Losartan - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
- ^ "Losartan And Hydrochlorothiazide (Oral Route) Description and Brand Names - Mayo Clinic". www.mayoclinic.org. Retrieved 5 April 2024.